Compare Quest Diagnostics Inc (DGX) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Keysight Technologies Inc — how do they compare? Quest Diagnostics Inc trades at $230.72 (market cap $25.06B), while Keysight Technologies Inc trades at $374.5 (market cap $64.93B). The key difference: Keysight Technologies Inc is far larger — about 2.6× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.52% dividend while Keysight Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Keysight Technologies Inc for 56 Days on average.
| DGX | KEYS | |
|---|---|---|
Market Cap | $25.06B | $64.93B |
Volume | 927,361 | 1,037,588 |
Sector | Health | Technology |
52-Week High | $247.45 | $387.90 |
52-Week Low | $173.49 | $159.49 |
Typical Hold Time | 56 Days | 56 Days |
Enterprise Value | $30.82B | $65.08B |
Dividend Yield | 1.52% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.03% with consistent earnings beats in recent quarters. The stock shows bearish technical signals despite strong fundamentals including 9.19% net margins and 14.35% ROE. Recent developments include a partnership with Apple Health app and concerns about Medicare reimbursement cuts affecting future revenue streams.
The outlook remains cautiously optimistic with a $250 consensus price target representing 8.3% upside potential. Key opportunities include growth in advanced diagnostics and consumer testing demand, while risks center on Medicare payment reductions and competitive pressures in the diagnostic services market.
Keysight Technologies (KEYS) trades at $374.66, down 3.41% on the day but remains in a bullish technical trend with strong analyst support. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.07 surpassing the $2.48 estimate. Revenue for 2025 reached $5.38 billion, with a net income margin of 15.81%. Recent news highlights growth in AI infrastructure and 6G testing solutions.
Outlook is positive driven by AI and 6G demand, but high valuation multiples pose a risk. The consensus price target of $416.63 implies 11% upside. Key risks include supply constraints and competitive pressures in the semiconductor testing space. Institutional sentiment remains bullish with 81% of analysts rating the stock a buy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
